Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples

NACompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

January 31, 2015

Conditions
Multiple Sclerosis
Interventions
OTHER

NA-NOSE artificial olfactory system

NA-NOSE is an artificial olfactory system that is based on nanomaterials and connected with machine learning. NA-NOSE can diagnosis diseases or disorders based on volatile biomarkers that are emitted from exhaled breath, blood, or from clinical tissue.

Trial Locations (1)

Unknown

Multiple Sclerosis Clinic, Carmel Medical Center, Haifa

Sponsors
All Listed Sponsors
collaborator

Technion, Israel Institute of Technology

OTHER

lead

Carmel Medical Center

OTHER